Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Source: techcrunch.com · Section: business-tech · Bias: Center · Published: Wed, 23 Sep 2026 19:31:28 GMT

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Read the full article at techcrunch.com →

The same story across the political spectrum (3 sources)

Center: This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month — www.marketwatch.com
Center: Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year — www.gizmodo.com
Center: Patients sue GLP-1 makers over sudden loss of vision — thehill.com

← Back to FlashTopics.com